Manulife (Manufacturers Life Insurance)’s Lyell Immunopharma LYEL Stock Holding History
Bought
Maintained
Sold
Other funds holding LYEL
AVM
MM
FCMI
OPL
DC
AC
FCMV
VP
Manulife (Manufacturers Life Insurance)'s LYEL Position: Q3 2025 in Review
Manulife (Manufacturers Life Insurance) sold out of Lyell Immunopharma (LYEL) in Q3 2025, closing a stake of 24,419 shares — an estimated $216K sold.
Manulife (Manufacturers Life Insurance) first reported a position in LYEL in Q3 2021 and held it in 16 quarters. The position peaked at $1.61M in Q3 2022. 59 funds tracked by Wall St. Rank hold LYEL as of Q3 2025.
- Manulife (Manufacturers Life Insurance) reported no remaining Lyell Immunopharma position as of Q3 2025 after selling out during the quarter.
- Manulife (Manufacturers Life Insurance) sold 24,419 Lyell Immunopharma shares in Q3 2025, an estimated $216K.
- Manulife (Manufacturers Life Insurance) first reported a position in Lyell Immunopharma in Q3 2021 and held it in 16 quarters.
- Manulife (Manufacturers Life Insurance)'s Lyell Immunopharma position peaked at $1.61M in Q3 2022.
- 59 funds tracked by Wall St. Rank held Lyell Immunopharma as of Q3 2025.
Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q3 2025, filed 14 Nov 2025.